Who
Peter McNamara
Chief Scientific Officer
Company insider
Files Form 4 as: Chief Scientific Officer, Tectonic Therapeutic.
In numbers
- Trades disclosed
- 57
- Buys
- 0
- Sells
- 7
- Bought
- $0
- Sold
- $564K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 20 Jun 2024
- Last trade
- 30 Sep 2026
- Last filed
- 2 Oct 2026
Companies traded
Activity over time
1 Mar – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 30 Sep 2026filed 2 Oct 2026 | TECX Tectonic TherapeuticBiotechnology | SEC FORM 4 Sold | $12K536 at $23.04 | filing |
| 25 Sep 2026filed 2 Oct 2026 | TECX Tectonic TherapeuticBiotechnology | SEC FORM 4 Code F | $11K444 at $23.67 | filing |
| 3 Sep 2026filed 8 Sep 2026 | TECX Tectonic Therapeuticoption or derivative · Biotechnology | SEC FORM 4 Code A | —21,000 at $0.00 | filing |
| 3 Sep 2026filed 8 Sep 2026 | TECX Tectonic Therapeuticoption or derivative · Biotechnology | SEC FORM 4 Code A | —21,000 at $0.00 | filing |
| 25 Aug 2026filed 26 Aug 2026 | TECX Tectonic TherapeuticBiotechnology | SEC FORM 4 Code M | $63343 at $14.71 | filing |
| 25 Aug 2026filed 26 Aug 2026 | TECX Tectonic TherapeuticBiotechnology | SEC FORM 4 Sold | $1,57043 at $36.52 | filing |
| 25 Aug 2026filed 26 Aug 2026 | TECX Tectonic Therapeuticoption or derivative · Biotechnology | SEC FORM 4 Code M | —43 at $0.00 | filing |
| 25 Aug 2026filed 26 Aug 2026 | TECX Tectonic Therapeuticoption or derivative · Biotechnology | SEC FORM 4 Code M | —43 at $0.00 | filing |
| 25 Aug 2026filed 26 Aug 2026 | TECX Tectonic TherapeuticBiotechnology | SEC FORM 4 Code M | $63343 at $14.71 | filing |
| 25 Aug 2026filed 26 Aug 2026 | TECX Tectonic TherapeuticBiotechnology | SEC FORM 4 Sold | $1,57043 at $36.52 | filing |
| 12 Aug 2026filed 14 Aug 2026 | TECX Tectonic TherapeuticBiotechnology | SEC FORM 4 Code M | $63343 at $14.71 | filing |
| 12 Aug 2026filed 14 Aug 2026 | TECX Tectonic TherapeuticBiotechnology | SEC FORM 4 Sold | $1,50543 at $35.00 | filing |
| 12 Aug 2026filed 14 Aug 2026 | TECX Tectonic Therapeuticoption or derivative · Biotechnology | SEC FORM 4 Code M | —43 at $0.00 | filing |
| 12 Aug 2026filed 14 Aug 2026 | TECX Tectonic Therapeuticoption or derivative · Biotechnology | SEC FORM 4 Code M | —43 at $0.00 | filing |
| 12 Aug 2026filed 14 Aug 2026 | TECX Tectonic TherapeuticBiotechnology | SEC FORM 4 Code M | $63343 at $14.71 | filing |
| 12 Aug 2026filed 14 Aug 2026 | TECX Tectonic TherapeuticBiotechnology | SEC FORM 4 Sold | $1,50543 at $35.00 | filing |
| 30 Jun 2026filed 1 Jul 2026 | TECX Tectonic TherapeuticBiotechnology | SEC FORM 4 Code M | $2,530172 at $14.71 | filing |
| 30 Jun 2026filed 1 Jul 2026 | TECX Tectonic TherapeuticBiotechnology | SEC FORM 4 Sold | $6,020172 at $35.00 | filing |
| 30 Jun 2026filed 1 Jul 2026 | TECX Tectonic Therapeuticoption or derivative · Biotechnology | SEC FORM 4 Code M | —172 at $0.00 | filing |
| 30 Jun 2026filed 1 Jul 2026 | TECX Tectonic Therapeuticoption or derivative · Biotechnology | SEC FORM 4 Code M | —172 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.